Clinical Trial: Assessment of a Novel Fixed-dose Combination (FDC) Drug VR-AD-1005 for the Treatment of Acute Watery Diarrhea in Cholera
Study Status: COMPLETED
Recruit Status: COMPLETED
Condition: Cholera
Study Type: INTERVENTIONAL
Official Title: Assessment of a Novel Fixed-dose Combination (FDC) Drug VR-AD-1005 for the Treatment of Acute Watery Diarrhea in Cholera: a Phase II, Randomized, Placebo-controlled, Double-blinded Efficacy and Safety
Brief Summary:
Cholera still remains a global public health concern affecting both children and adults, and patients can succumb in quick time if remain untreated.Cholera is a secretory diarrhea and is generally treated with oral or intravenous rehydration therapy to compensate for the fluid loss.However, antimicrobial treatment is given to patients with moderate to severe diarrhea.The consistent emergence of multidrug-resistant bacteria is a major concern for the management of infectious diseases including cholera.No…
Read more